Accès à distance ? S'identifier sur le proxy UCLouvain
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib.
Primary tabs
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Access type | Accès restreint |
Publication date | 2016 |
Language | Anglais |
Journal information | "OncoTarget" - Vol. 7, no. 45, p. 72622-72633 (2016) |
Peer reviewed | yes |
Publisher | Impact Journals LLC ((United States) Albany, NY) |
e-issn | 1949-2553 |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC - Institut de recherche expérimentale et clinique UCL - SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie UCL - (SLuc) Service d'hépato-gastro-entérologie |
Keywords | AFP ; HCC ; HGF ; MET ; Sorafenib |
Links |
Bibliographic reference | Rimassa, Lorenza ; Abbadessa, Giovanni ; Personeni, Nicola ; Porta, Camillo ; Borbath, Ivan ; et. al. Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib.. In: OncoTarget, Vol. 7, no. 45, p. 72622-72633 (2016) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/180142 |